Navigation Links
Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting

g and occurrence of anticipated clinical trials, and potential collaborations or extensions of existing collaborations. These statements are based on certain assumptions made by Neurogen based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various factors, including, but not limited to, risks associated with the inherent uncertainty of drug research and development, difficulties or delays in development, testing, regulatory approval, production and marketing of any of Neurogen's drug candidates, adverse side effects or inadequate therapeutic efficacy or pharmacokinetic properties of Neurogen's drug candidates or other properties of drug candidates which could make them unattractive for commercialization, advancement of competitive products, dependence on corporate partners, Neurogen's ability to retain key employees, sufficiency of cash to fund Neurogen's planned operations and patent, product liability and third party reimbursement risks associated with the pharmaceutical industry. Although Neurogen believes that its expectations are based on reasonable assumptions, it can give no assurance that the anticipated results will occur. For such statements, Neurogen claims the protection of applicable laws. Future results may also differ from previously reported results. For example, positive results or safety and tolerability in one clinical study provides no assurance that this will be true in future studies. Forward-looking statements represent the judgment of Neurogen's management as of the date of this release and Neurogen disclaims any intent and does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required under applic
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials
2. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
3. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
4. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
5. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
8. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
9. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
10. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
11. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
Post Your Comments:
(Date:5/28/2015)... , May 28, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-five. ... the Company, commented, "Our team continues to execute on ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ...   report to their offering.  ... provides a worldwide strategic overview of the ... regions, market segments and product categories. , ...
(Date:5/27/2015)... 2015 Research and ... of the  "North America Mammography Market - ...  report to their offering. ... a detailed type of imaging that customs ... A mammography exam, called a mammogram, is ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Third ANDA Submission Of 2015 2Global Orthopedics Market Strategies 2015 2North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2
(Date:5/28/2015)... 28, 2015 A bucket list should ... Each item on the bucket list can be ... and tasks that the owner wants to happen in ... wrong when it comes to making this list. ... poems, publishing a book, seeing the Grand Canyon on ...
(Date:5/28/2015)... May 28, 2015 The MIT Sloan ... study featuring Healthcare IQ. Members of the MIT CISR ... management team to develop the case study about Healthcare ... analytics. , The case study, ‘Healthcare IQ: Competing as ... from its beginning as a hospital financial software provider ...
(Date:5/28/2015)... Orem, UT—Dymicron, Inc., (dymicron.com) confirmed the ... unique Triadyme-C cervical total disc replacement device. The two ... Smith at the American Institute of Minimally Invasive Surgery ... well to the implantation of the Dymicron devices,” said ... and Chief of Neurosurgery for the University Medical Center, ...
(Date:5/28/2015)... May 28, 2015 Aureus Medical Group ... nurse practitioner jobs, has announced that it will participate ... Practitioners’ 2015 National Conference to be held June 9-14, ... offers educational programming, networking opportunities, and exhibits with products ... Advanced Practice division will be available to speak ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Peggy J. Lynam, ... Delegate to the American Physical Therapy Association House of Delegates ... Delegation at their Delegate Assembly. This will be her ... Delegates serves as coordinator and principle spokesperson for the Chapter ... Board of Directors or Delegate Assembly may direct the Chief ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... Being married improves the likelihood of survival for colon cancer ... with colon cancer were 14 percent less likely to die ... analyzed 127,753 patient records. The study also found that ... and sought more aggressive treatment, which echoes findings from studies ...
... Researchers at the Georgia Tech Research Institute (GTRI) have ... with Parkinson,s disease and certain other neurological conditions to ... and arm tremors and relay the results to medical ... application could replace subjective tests now used to assess ...
... Ariz. June 23, 2011 A new ... EVO 200 liquid handling platform has been developed ... with the Translational Genomics Research Institute (TGen) and ... The fully automated, integrated, high-throughput system is ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) ... the neck may mean more headache-free days for people ... a new study suggests. More than 36 million ... pain, sensitivity to light and sound, nausea and vomiting, ...
... of Singapore,s leading writers and poets and their international ... an international conference of literature and the arts, organised ... Presented by the University,s Division of English and the ... The Contemporary conference will feature prominent local writers and ...
... The Woods Institute for the Environment at Stanford University ... for interdisciplinary research aimed at finding practical solutions promoting ... grants totaling $1,025,000 over two years to tackle a ... American Samoa to groundwater supply in China. The seven ...
Cached Medicine News:Health News:New application for iPhone may support monitoring and research on Parkinson's disease 2Health News:New application for iPhone may support monitoring and research on Parkinson's disease 3Health News:Implantable Device May Help Ease Tough Migraines 2Health News:Implantable Device May Help Ease Tough Migraines 3Health News:NTU hosts landmark conference on contemporary literature and the arts 2Health News:Stanford Woods Institute awards Environmental Venture Projects 2Health News:Stanford Woods Institute awards Environmental Venture Projects 3Health News:Stanford Woods Institute awards Environmental Venture Projects 4
... Volk's super ... biomicroscopy lenses. General ... Provide unprecedented fundus ... addressing maximum potential ...
Volk indirect lenses. High magnification views of the posterior pole....
Precision has its new line of programmable autoclaves which are easy to use bench-top autoclaves or models to fit any need. It has 4 adjustable sterilization programs, touch button control panel, man...
... The Heidelberg Retina Tomograph is ... acquisition and analysis of three-dimensional images ... the quantitative assessment of the retinal ... changes. The most important clinical routine ...
Medicine Products: